Chang P.-Y.PO-REN HSUEHWu P.-S.Chan P.-C.Yang T.-T.CHUN-YI LULUAN-YIN CHANGJONG-MIN CHENPING-ING LEECHIN-YUN LEELI-MIN HUANG2021-06-242021-06-2420071684-1182https://www.scopus.com/inward/record.uri?eid=2-s2.0-38049058936&partnerID=40&md5=70600c227456f8a3d6709520013c6c63https://scholars.lib.ntu.edu.tw/handle/123456789/566572[SDGs]SDG3amikacin; aminoglycoside; antibiotic agent; antineoplastic agent; aztreonam; carbapenem derivative; cefepime; ceftazidime; cephalosporin; ciprofloxacin; gentamicin; imipenem; macrolide; meropenem; minocycline; ofloxacin; penicillin derivative; quinolone derivative; sultamicillin; timentin; Acinetobacter baumannii; adolescent; adult; article; bacterial colonization; bacterium isolate; cancer chemotherapy; child; child care; congenital heart disease; controlled study; female; gastrointestinal symptom; hematologic disease; host resistance; human; infant; intensive care; major clinical study; major surgery; male; mortality; multidrug resistance; neoplasm; neurologic disease; neutropenia; newborn; newborn disease; outcome assessment; pathogenesis; perineum; peritonitis; pneumonia; sepsis; Taiwan; university hospital; urinary tract infection; ventilator; wound infection; Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Hospitals, University; Humans; Infant; Infant, Newborn; Male; Perineum; Peritonitis; Pneumonia; Risk Factors; Sepsis; Taiwan; Urinary Tract Infections; Wound Infectionjournal article179326002-s2.0-38049058936